Fragile X Syndrome: Recent Research Updates toward Capturing Treatments’ Improvement in Clinical Trials

This Brain Sciences 2020 Special Issue of nine manuscripts contribute novel data on treatment updates in fragile X syndrome (FXS) [...].

[1]  E. Berry-Kravis.  Disease-Targeted Treatment Translation in Fragile X Syndrome as a Model for Neurodevelopmental Disorders , 2022, Journal of child neurology.

[2]  R. Hagerman,et al.  Fragile X Syndrome: From Molecular Aspect to Clinical Treatment , 2022, International journal of molecular sciences.

[3]  J. Piven,et al.  Cognitive Training Deep Dive: The Impact of Child, Training Behavior and Environmental Factors within a Controlled Trial of Cogmed for Fragile X Syndrome , 2020, Brain sciences.

[4]  W. Kaufmann,et al.  Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis , 2020, Brain sciences.

[5]  Kevin Sharp,et al.  A Genotype-Phenotype Study of High-Resolution FMR1 Nucleic Acid and Protein Analyses in Fragile X Patients with Neurobehavioral Assessments , 2020, Brain sciences.

[6]  N. Tartaglia,et al.  Adaptive Skills in FXS: A Review of the Literature and Evaluation of the PEDI-Computer Adaptive Test (PEDI-CAT) to Measure Adaptive Skills , 2020, Brain sciences.

[7]  E. Berry-Kravis,et al.  Delineating Repetitive Behavior Profiles across the Lifespan in Fragile X Syndrome , 2020, Brain sciences.

[8]  E. Coan,et al.  Evaluating Social Interactions Using the Autism Screening Instrument for Education Planning-3rd Edition (ASIEP-3): Interaction Assessment in Children and Adults with Fragile X Syndrome , 2020, Brain sciences.

[9]  L. Schmitt,et al.  Examination of Correlates to Health-Related Quality of Life in Individuals with Fragile X Syndrome , 2020, Brain sciences.

[10]  E. Berry-Kravis,et al.  Language across the Lifespan in Fragile X Syndrome: Characteristics and Considerations for Assessment , 2020, Brain sciences.

[11]  J. Sweeney,et al.  The Relationship between Expressive Language Sampling and Clinical Measures in Fragile X Syndrome and Typical Development , 2020, Brain sciences.

[12]  Matt A. King,et al.  Updated report on tools to measure outcomes of clinical trials in fragile X syndrome , 2017, Journal of Neurodevelopmental Disorders.